Monique G de Sain-van der Velden
Overview
Explore the profile of Monique G de Sain-van der Velden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veldman A, Sikkema-Raddatz B, Derks T, van Karnebeek C, Kiewiet M, Mulder M, et al.
Int J Neonatal Screen
. 2025 Jan;
11(1.
PMID: 39846587
The biomarker-based Dutch Newborn Screening (NBS) panel (as of 2024) comprises 19 inherited metabolic disorders (IMDs). With the use of next-generation sequencing (NGS) as a first-tier screen, NBS could expand...
2.
Veldman A, Kiewiet M, Westra D, Bosch A, Brands M, de Coo R, et al.
Int J Neonatal Screen
. 2023 Oct;
9(4).
PMID: 37873847
The Wilson and Jungner (W&J) and Andermann criteria are meant to help select diseases eligible for population-based screening. With the introduction of next-generation sequencing (NGS) methods for newborn screening (NBS),...
3.
Marquardt G, Currier R, McHugh D, Gavrilov D, Magera M, Matern D, et al.
Genet Med
. 2012 Jul;
14(7):648-55.
PMID: 22766634
Purpose: To improve quality of newborn screening by tandem mass spectrometry with a novel approach made possible by the collaboration of 154 laboratories in 49 countries. Methods: A database of...
4.
McHugh D, Cameron C, Abdenur J, Abdulrahman M, Adair O, Al Nuaimi S, et al.
Genet Med
. 2011 Feb;
13(3):230-54.
PMID: 21325949
Purpose: To achieve clinical validation of cutoff values for newborn screening by tandem mass spectrometry through a worldwide collaborative effort. Methods: Cumulative percentiles of amino acids and acylcarnitines in dried...
5.
Visser G, van Spronsen F, de Sain-van der Velden M, Blom H, Wijburg F
Ned Tijdschr Geneeskd
. 2009 May;
153(18):848-53.
PMID: 19475862
No abstract available.
6.
Westermann C, Dorland B, de Sain-van der Velden M, Wijnberg I, van Breda E, De Graaf-Roelfsema E, et al.
Am J Vet Res
. 2008 Nov;
69(11):1469-75.
PMID: 18980429
Objective: To evaluate alterations in skeletal muscle carnitine metabolism during exercise and training by measuring changes in plasma acylcarnitine concentrations in Standardbreds. Animals: 10 Standardbred geldings with a mean +/-...
7.
Vissers M, Trip M, Pritchard P, Tam P, Lukic T, de Sain-van der Velden M, et al.
Eur J Clin Pharmacol
. 2008 Mar;
64(7):651-61.
PMID: 18320185
Objective: This study investigated the efficacy, safety, tolerability, and pharmacokinetics of a novel cholesterol absorption inhibitor, FM-VP4, comprising disodium ascorbyl sitostanol phosphate (DASP) and disodium ascorbyl campestanol phosphate (DACP). Methods:...
8.
Fuchs S, de Barse M, Scheepers F, Cahn W, Dorland L, de Sain-van der Velden M, et al.
Eur Neuropsychopharmacol
. 2008 Feb;
18(5):333-8.
PMID: 18261886
N-Methyl D-aspartate (NMDA)-receptor hypofunction has been implicated in the pathophysiology of schizophrenia and D-serine and glycine add-on therapy to antipsychotics has shown beneficial effects in schizophrenic patients. Nevertheless, previous studies...
9.
Fuchs S, Dorland L, de Sain-van der Velden M, Hendriks M, Klomp L, Berger R, et al.
Ann Neurol
. 2006 Oct;
60(4):476-80.
PMID: 17068790
To elucidate the role of D-serine in human central nervous system, we analyzed D-serine, L-serine, and glycine concentrations in cerebrospinal fluid of healthy children and children with a defective L-serine...